Carulli Michael 4
4 · PMV Pharmaceuticals, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Carulli Michael
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-01$1.06/sh−28,249$30,077→ 60,146 total
Footnotes (1)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.